Learning Outcomes
Upon completion of the course, the students will be able to better understand the drug effects in the organism at the molecular level by focusing on: 1) the analysis of patient response heterogeneity issues seen in drug delivery; 2) correlations and implementation in clinical practice of specific pharmacogenomic biomarkers with pharmacological effects, thus improving the drug prescription outcome; 3) assessing the effects of drug metabolizing enzymes and transporters in the pharmacokinetic processes of drugs administered in the body; and 4) developing skills on Systems Pharmacology and Quantitative Pharmacology to advance their predictive capacity in pharmacotherapy issues related to drugs safety and efficiency/efficacy.
Course Content (Syllabus)
The evolution of pharmacogenetics into pharmacogenomics in modern pharmacology. Genomic technologies and pharmacological drug development. Experimental methodologies for clinical utilization of pharmacogenomic data. Genetic polymorphism of metabolic enzymes and drug transporters. Differential pharmacological response in clinical practice. Pharmacogenomic approach to enhance drug safety in clinical practice. Pharmacogenomic databases. Pharmacogenomics of anticancer drugs. Pharmacogenomics and cardiotoxicity. Drug hepatotoxicity and pharmacogenomics. Drug prescription and pharmacogenomic data.
Keywords
pharmacogenomics, drug toxicity, adverse drug reactions, drug prescription, molecular biomarkers
Course Bibliography (Eudoxus)
Βιβλίο [94690214]: Εγχειρίδιο εξατομικευμένης ιατρικής, Συλλογικό έργο, Επιμ. ξένης έκδοσης Vizirianakis Ioannis, Επιμ. ελλην. έκδοσης Βιζιριανάκης Ιωάννης, Ελλην. έκδοση University Studio Press